Adam Rosenberg

Our platform consists of three fundamental elements: our drug discovery toolbox, 14-3-3 encyclopedia and diverse compound library. Each helps us expand the druggable proteome. To find additional details about our platform, visit our site at ambagontx.com/platform-pipel…

@LifeSciVC Then you really had no excuse passing on our zebrafish company

Article made me think about my childhood hobby: I loved breeding tropical cichlid species (+ gouramis & angelfish). They'd spawn in spring, we'd put babies out in our pond in summer, where they'd grow fast, & then we'd catch them in fall, sell them to local fish stores #FunFact

The father of a Harry Potter fan tries to shed some light on the role of EIRs and venture partners @ biotech vcs rapport.bio/all-stories/ve…

Want to make a difference for our troops? Please check out #SneakersForSoldiers and my testimonial on ABC World News Tonight #AmericaStrong youtube.com/watch?v=cguXy7…

RIP Flossie Wong-Staal, an American hero AND daughter of China. 1st to clone HIV, leading to treatments saving lives. Proof the world can work together.❤️

Definitely better than a zoom graduation powder.com/stories/news/t…

@LifeSciVC @alexharding @endpts @atlasventure Congrats @alexharding - a rockstar in the board room and the emergency room (and allegedly the rugby pitch as well)

Great to see @AlexHarding on this @endpts list of "20 under 40"... He's exceptional and we're lucky to have him on the @atlasventure team! endpts.com/the-20-under-4…

More evidence for SV2A PET as a marker of synaptic density apple.news/A-iQ2I4SORPiFQ…

Anyone investing or operating early stage drug discovery ought to give a read for the lessons learned here, and read through the end to get to the "why" - moving lessons about patients we all know, and why we do what we do.

Thinking Boldly: Alkermes Acquires Rodin Therapeutics. lifescivc.com/2019/11/thinki… $ALKS

Very proud of what our team ⁦@Rodintx⁩ has accomplished over 4+ years of cutting-edge research in challenging neurological areas with massive unmet need - look forward to continued progress ⁦@Alkermes⁩ prnewswire.co.uk/news-releases/…

@LifeSciVC @Bobmorevc That’s a very average response. But at least it wasn’t a mean response.

@Bobmorevc Not arguing the point... but doesn’t this say median, Bob? :)

@LifeSciVC Wait, I thought it was our audit committee call you were on at the time that made your commute less painful?

Only in Cambridge: I’m stuck in traffic on the exit from the Pike and a biotech CEO pulls up next to me, rolls window down and says “Hey Bruce, we’ve got great NHP efficacy data... can’t wait to show you”... Made my commute far less painful! This ecosystem never ceases to amaze

Excellent thread on capital efficiency by @epaley; relevant to tech and biotech

Great piece by Halley Gilbert of @allergyamulet, @ironwoodpharma and @biodirector1 on overseas family travel with #foodallergies (and yes, I am the unnamed food suitcase advisor...)

Excited for Ajim to join the team!

Great piece re: the power of #zebrafish for in vivo drug screening; faster, cheaper and least in some cases, preferable to rodents

Thanks @jonrohrer and @FTDtalk for a terrific #GENFI Therapeutics Meeting about clinical, cognitive, imaging and fluid biomarker outcome measures in genetic #FTD. And congratulations on reaching 1000 GENFI participants!

Great job by entire @Rodintx team to achieve this important milestone on the way towards making a difference for patients with neurologic disease; while this may get a bit lost in today’s other news, designing a novel molecule and reaching clinical safety data is no small feat!

An Ironman’s Fight against Parkinson’s sanofi.com/en/science-and…